Periocular Rejuvenation by Topical Hyaluronic Acid Nano Particles

Last updated: January 29, 2025
Sponsor: Alexandria University
Overall Status: Completed

Phase

1/2

Condition

Birth Defects

Holoprosencephaly

Treatment

Hyaluronic acid NanoGel

Placebo gel

Clinical Study ID

NCT05742399
0305360
00012098
  • Ages 21-65
  • All Genders

Study Summary

In this study, The investigators aims to evaluate the efficacy and safety of topical hyaluronic acid nanoparticles as a novel nanodermatological tool in periocular rejuvenation as a replacement approach of invasive dermal filler injections.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Is a healthy male or female between 21 and 65 years old

  2. Is voluntarily willing to consent to participate in the study

  3. Is willing to comply with all requirements of the study including beingphotographed, follow post treatment care instructions, to attend all treatment, andfollow up visits

  4. Willingness to waive rights to use of still photos of themselves for research,marketing, or promotional reasons, including on the internet and on social mediaoutlets.

  5. Willingness to refrain from other surgical, laser, or injectable treatments in theperiorbital region during the entire duration of the study.

  6. Ability to provide informed consent.

Exclusion

Exclusion Criteria:

Study Design

Total Participants: 30
Treatment Group(s): 2
Primary Treatment: Hyaluronic acid NanoGel
Phase: 1/2
Study Start date:
December 21, 2022
Estimated Completion Date:
January 15, 2024

Study Description

Tear trough deformity is a main concern of many people (males or females) with age range of 21 to 65 years old or older. Such condition is characterized by a sunken appearance of the eye that results in an aged and dissipated appearance to the eye.Treatment modalities range from camouflage make up, laser resurfacing, platelet-rich plasma therapy, carboxy therapy, mesotherapy, volume augmentation with injectable hyaluronic acid fillers and fat, as well as surgical procedures such as blepharoplasty. Consequently, safe, effective and less invasive treatment options of the tear trough have remained a challenge.

The study will include 30 adult patients (male or female) suffering tear trough deformity.

They will be selected from Dermatology Outpatient Clinic of Alexandria Main University Hospital.

Connect with a study center

  • Shaimaa Ismail Omar

    Alexandria, Elazarita 21500
    Egypt

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.